QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 165 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $11,294,000 | -58.4% | 505,551 | -48.7% | 0.02% | -57.4% |
| Q4 2015 | $27,160,000 | +83.1% | 984,835 | +71.0% | 0.05% | +67.9% |
| Q3 2015 | $14,830,000 | -12.9% | 575,852 | -16.4% | 0.03% | +3.7% |
| Q2 2015 | $17,031,000 | +19.3% | 688,763 | +21.6% | 0.03% | +3.8% |
| Q1 2015 | $14,279,000 | +128.4% | 566,314 | +113.3% | 0.03% | +136.4% |
| Q4 2014 | $6,251,000 | +5.5% | 265,506 | +2.2% | 0.01% | 0.0% |
| Q3 2014 | $5,925,000 | +11.5% | 259,774 | +18.7% | 0.01% | +22.2% |
| Q2 2014 | $5,316,000 | -19.5% | 218,875 | -30.5% | 0.01% | -25.0% |
| Q1 2014 | $6,604,000 | +25.7% | 314,938 | +40.5% | 0.01% | +20.0% |
| Q4 2013 | $5,255,000 | -32.3% | 224,135 | -37.9% | 0.01% | -28.6% |
| Q3 2013 | $7,758,000 | +34.5% | 360,824 | +23.0% | 0.01% | +27.3% |
| Q2 2013 | $5,767,000 | – | 293,325 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tikvah Management LLC | 369,425 | $9,032,000 | 6.36% |
| Hardman Johnston Global Advisors LLC | 4,586,856 | $112,149,000 | 5.99% |
| Eclectica Asset Management LLP | 90,950 | $2,223,000 | 2.21% |
| Douglas C. Lane & Associates, Inc. | 1,970,371 | $48,176,000 | 1.46% |
| HARDING LOEVNER LP | 6,978,369 | $170,621,000 | 1.27% |
| CRAMER ROSENTHAL MCGLYNN LLC | 3,911,835 | $95,644,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,781,076 | $43,547,000 | 0.76% |
| GLG Partners LP | 1,220,148 | $29,833,000 | 0.71% |
| Sivik Global Healthcare LLC | 49,451 | $1,209,000 | 0.61% |
| PRIMECAP MANAGEMENT CO/CA/ | 22,087,404 | $540,037,000 | 0.59% |